Your browser doesn't support javascript.
loading
PARP inhibition in BRCA2-mutated prostate cancer.
Nientiedt, C; Tolstov, Y; Volckmar, A-L; Endris, V; Bonekamp, D; Haberkorn, U; Jäger, D; Sültmann, H; Stenzinger, A; Hohenfellner, M; Grüllich, C; Duensing, S.
Affiliation
  • Nientiedt C; Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Tolstov Y; Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Volckmar AL; Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Endris V; Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Bonekamp D; Department of Radiology, German Cancer Research Center, Heidelberg, Germany.
  • Haberkorn U; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Jäger D; Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Sültmann H; German Cancer Research Center, Cancer Genome Research, and German Cancer Consortium, Heidelberg, Heidelberg, Germany.
  • Stenzinger A; Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Hohenfellner M; Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Grüllich C; Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Duensing S; National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany.
Ann Oncol ; 28(1): 189-191, 2017 01 01.
Article in En | MEDLINE | ID: mdl-27687312
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Piperazines / Germ-Line Mutation / BRCA2 Protein / Prostatic Neoplasms, Castration-Resistant / Poly(ADP-ribose) Polymerase Inhibitors Limits: Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Piperazines / Germ-Line Mutation / BRCA2 Protein / Prostatic Neoplasms, Castration-Resistant / Poly(ADP-ribose) Polymerase Inhibitors Limits: Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country: